全球移植市場規模、佔有率、成長分析、按應用、按最終用途 - 產業預測，2024-2031 年

Global Transplantation Market Size, Share, Growth Analysis, By Application(Organ Transplantation, and Tissue Transplantation), By End-Use(Hospitals, Transplant Centers) - Industry Forecast 2024-2031

出版日期: 2024年04月05日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球移植市場規模預計為150億美元，從2023年的164億美元成長到2031年的333.9億美元，預測期內（2024-2031年）年複合成長率為9.3%。

移植市場在為器官衰竭患者提供恢復器官功能和改善生活品質的可行選擇方面發揮著重要作用。由於老化和生活方式改變等因素，全球慢性病盛行率不斷上升，推動了這一成長。腎臟病、肝病和心臟衰竭等疾病極大地導致了移植手術需求的增加。此外，手術技術、免疫抑制劑和組織工程技術的進步顯著提高了移植成功率，進一步推動了市場擴張。然而，由於移植手術的複雜性，該領域面臨挑戰，需要專門的基礎設施、熟練的醫療專業人員和全面的移植後護理。與移植相關的高昂費用，例如移植前評估、手術、後續護理和免疫抑制藥物，給醫療保健系統和患者帶來了經濟負擔，並影響了獲得移植服務的機會。然而，用於器官保存的機器灌注和新型免疫抑制藥物的市場開拓等技術創新有可能改善移植結果，並且移植市場存在著有希望的成長機會。此外，旨在提高人們對器官捐贈和移植的認知、政府支持以及醫療保健營業單位之間的合作的舉措有望解決器官短缺和擴大移植計劃。為了滿足快速成長的需求並改善全球移植服務的可近性，在研究、基礎設施增強和公共教育方面的持續努力至關重要。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

美敦力（美國）
諾華公司（瑞士）
艾伯維公司（美國）
Zimmer Biomet Holdings, Inc.（美國）
史賽克公司（美國）
CSL 有限公司（澳洲）
強生公司（美國）
羅氏控股公司（瑞士）
輝瑞公司（美國）
賽諾菲（法國）
默克公司（美國）
安斯泰來製藥公司（日本）
百時美施貴寶公司（美國）
武田藥品工業株式會社（日本）
阿斯特捷利康（英國）
葛蘭素史克公司（英國）
Fresenius Medical Care AG & Co. KGaA（德國）
Integra LifeSciences Holdings Corporation（美國）
Organogenesis Holdings Inc.（美國）
泰爾茂株式會社（日本）

簡介目錄

Product Code: SQMIG35D2158

Global Transplantation Market size was valued at USD 15 Billion in 2022 and is poised to grow from USD 16.4 Billion in 2023 to USD 33.39 Billion by 2031, at a CAGR of 9.3% during the forecast period (2024-2031).

The transplantation market plays a crucial role in offering patients suffering from organ failure a viable option to restore organ function and enhance their quality of life. Its growth is fueled by the escalating prevalence of chronic diseases globally, driven by factors like aging populations and lifestyle changes. Conditions such as kidney disease, liver disease, and heart failure contribute significantly to the increasing demand for transplantation procedures. Moreover, advancements in surgical techniques, immunosuppressive medications, and tissue engineering technologies have notably improved transplant success rates, further stimulating market expansion. However, the sector faces challenges due to the intricate nature of transplant procedures, necessitating specialized infrastructure, skilled healthcare professionals, and comprehensive post-transplant care. The high costs associated with transplantation, including pre-transplant evaluations, surgeries, follow-up care, and immunosuppressive medications, create financial strains on healthcare systems and patients, affecting access to transplantation services. Nevertheless, the transplantation market presents promising opportunities for growth, with technological innovations such as machine perfusion for organ preservation and the development of novel immunosuppressive drugs offering potential to enhance transplant outcomes. Additionally, initiatives aimed at increasing awareness about organ donation and transplantation, along with governmental support and collaborations among healthcare entities, hold promise in addressing the organ shortage and expanding transplantation programs. Sustained efforts in research, infrastructure enhancement, and public education are essential to meet the escalating demand and improve access to transplantation services globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segmental Analysis

The global transplantation market is segmented on the basis of application, end-use, and region. By application, the market is segmented into organ transplantation, and tissue Transplantation. By End-Use, the market is segmented into hospitals, transplant centers, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Transplantation Market

The increasing prevalence of chronic illnesses like end-stage renal disease, liver cirrhosis, heart failure, and respiratory disorders has driven the need for organ transplantation. This is evidenced by the surge in demand for procedures such as kidney and pancreas transplants, spurred by the expanding diabetic population and its associated complications.

Restraints in the Global Transplantation Market

The process of organ transplantation encompasses substantial expenses, spanning from pre-transplant assessments to surgery, post-operative recuperation, and the ongoing necessity of immunosuppressive drugs. These financial demands place strains on patients, healthcare systems, and insurance companies alike. Moreover, the inadequate coverage and reimbursement schemes for transplant-related procedures exacerbate the challenges surrounding the affordability and availability of transplantation services.

Market Trends of the Global Transplantation Market

Precision medicine strategies seek to customize transplant treatments by taking into account unique genetic profiles, immunological compatibility, and specific disease attributes. This approach involves employing biomarkers, genetic assessments, and sophisticated diagnostic tools to individualize immunosuppressive treatments, thereby enhancing patient results.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Transplantation Market by Application

Market Overview
Organ Transplantation
and Tissue Transplantation

Global Transplantation Market by End-Use

Market Overview
Hospitals
Transplant Centers
and Others

Global Transplantation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments